133 related articles for article (PubMed ID: 23510454)
21. S100B protein in neurodegenerative disorders.
Steiner J; Bogerts B; Schroeter ML; Bernstein HG
Clin Chem Lab Med; 2011 Mar; 49(3):409-24. PubMed ID: 21303299
[TBL] [Abstract][Full Text] [Related]
22. Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier.
Pakulski C; Drobnik L; Millo B
Med Sci Monit; 2000; 6(2):314-8. PubMed ID: 11208329
[TBL] [Abstract][Full Text] [Related]
23. Delirium and cerebrospinal fluid S100B in hip fracture patients: a preliminary study.
Hall RJ; Ferguson KJ; Andrews M; Green AJ; White TO; Armstrong IR; MacLullich AM
Am J Geriatr Psychiatry; 2013 Dec; 21(12):1239-43. PubMed ID: 23602305
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of cerebrospinal fluid S100B protein concentration in patients with purulent, bacterial meningitis - own observations.
Kepa L; Oczko-Grzesik B
Przegl Epidemiol; 2013; 67(3):415-9, 525-8. PubMed ID: 24340553
[TBL] [Abstract][Full Text] [Related]
25. Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.
Steinacker P; Mollenhauer B; Bibl M; Cepek L; Esselmann H; Brechlin P; Lewczuk P; Poser S; Kretzschmar HA; Wiltfang J; Trenkwalder C; Otto M
Neurosci Lett; 2004 Nov; 370(1):36-9. PubMed ID: 15489013
[TBL] [Abstract][Full Text] [Related]
26. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics.
Reiber H
Restor Neurol Neurosci; 2003; 21(3-4):79-96. PubMed ID: 14530572
[TBL] [Abstract][Full Text] [Related]
27. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
[TBL] [Abstract][Full Text] [Related]
28. S100B as a biomarker of blood-brain barrier disruption after thoracoabdominal aortic aneurysm repair: a secondary analysis from a prospective cohort study.
Roberts DJ; Hall RI; Wang Y; Julien LC; Wood J; Goralski KB
Can J Anaesth; 2021 Dec; 68(12):1756-1768. PubMed ID: 34570352
[TBL] [Abstract][Full Text] [Related]
29. The use of S100B and Tau protein concentrations in the cerebrospinal fluid for the differential diagnosis of bacterial meningitis: a retrospective analysis.
Jung K; Goerdt C; Lange P; Blocher J; Djukic M; Gerber J; Spreer A; Nau R; Otto M; Schmidt H
Eur Neurol; 2011; 66(3):128-32. PubMed ID: 21865761
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt-Jakob disease.
Jacobi C; Arlt S; Reiber H; Westner I; Kretzschmar HA; Poser S; Zerr I
Acta Neurol Scand; 2005 Mar; 111(3):185-90. PubMed ID: 15691288
[TBL] [Abstract][Full Text] [Related]
31. Is the blood-CSF barrier altered in disease?
Seyfert S; Faulstich A
Acta Neurol Scand; 2003 Oct; 108(4):252-6. PubMed ID: 12956858
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers of Brain Damage: S100B and NSE Concentrations in Cerebrospinal Fluid--A Normative Study.
Hajduková L; Sobek O; Prchalová D; Bílková Z; Koudelková M; Lukášková J; Matuchová I
Biomed Res Int; 2015; 2015():379071. PubMed ID: 26421286
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Cepek L; Brechlin P; Steinacker P; Mollenhauer B; Klingebiel E; Bibl M; Kretzschmar HA; Wiltfang J; Otto M
Dement Geriatr Cogn Disord; 2007; 23(1):22-8. PubMed ID: 17068393
[TBL] [Abstract][Full Text] [Related]
34. [Neurospecific proteins in cerebrospinal fluid and in the bloodserum of patients with amyotrophic lateral sclerosis].
Rushkevich YN; Pashkouskaya ID; Likhachev SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):75-80. PubMed ID: 29927408
[TBL] [Abstract][Full Text] [Related]
35. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages.
Shiga Y; Wakabayashi H; Miyazawa K; Kido H; Itoyama Y
J Clin Neurosci; 2006 Jul; 13(6):661-5. PubMed ID: 16815706
[TBL] [Abstract][Full Text] [Related]
36. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases.
Tumani H; Nau R; Felgenhauer K
Ann Neurol; 1998 Dec; 44(6):882-9. PubMed ID: 9851432
[TBL] [Abstract][Full Text] [Related]
37. Determinants of lumbar CSF protein concentration.
Seyfert S; Kunzmann V; Schwertfeger N; Koch HC; Faulstich A
J Neurol; 2002 Aug; 249(8):1021-6. PubMed ID: 12195448
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.
Moritz S; Warnat J; Bele S; Graf BM; Woertgen C
J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011
[TBL] [Abstract][Full Text] [Related]
39. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
Blennow K; Lind B; Andersson E; Andreasen N
Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
[TBL] [Abstract][Full Text] [Related]
40. Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease.
Wong BS; Green AJ; Li R; Xie Z; Pan T; Liu T; Chen SG; Gambetti P; Sy MS
J Pathol; 2001 May; 194(1):9-14. PubMed ID: 11329135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
